Matches in Nanopublications for { ?s ?p "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP640442.RAW8X2XOj6hqVJfdLuKFukKyMC9FkgWPwEJZYIlGjbP1I130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640442.RAW8X2XOj6hqVJfdLuKFukKyMC9FkgWPwEJZYIlGjbP1I130_provenance.
- assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP472826.RAZRZiUJtJ6vki_tsO7LcZcM-0F6erHT5gMmxfKsglVgk130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472826.RAZRZiUJtJ6vki_tsO7LcZcM-0F6erHT5gMmxfKsglVgk130_provenance.
- NP472827.RAT44lU_kx9KrIxUZtq_tRj75CB1E9P511y0awPd2m134130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472827.RAT44lU_kx9KrIxUZtq_tRj75CB1E9P511y0awPd2m134130_provenance.
- NP472825.RAksvHlGua57E2Ws1gbgIZmnGWixHrujDCefx1VkH-SpI130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472825.RAksvHlGua57E2Ws1gbgIZmnGWixHrujDCefx1VkH-SpI130_provenance.
- NP640431.RAnKkf9u849zQy1uhtrdv42fvkj_z0C2CZK_uMiku0akI130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640431.RAnKkf9u849zQy1uhtrdv42fvkj_z0C2CZK_uMiku0akI130_provenance.
- NP640435.RAiHDdqtxLqr07zo88fEcB8yH-6prrL4cYqyeC5Z0aFkQ130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640435.RAiHDdqtxLqr07zo88fEcB8yH-6prrL4cYqyeC5Z0aFkQ130_provenance.